Pfizer’s CEO Albert Bourla announced this week about $5.6 million in company stock (announced on the same day that its Covid-19 vaccine has achieved positive results). The timing of the sale is being influenced by some investors. Review.
Mr. Bourla sold about 60% of Pfizer’s personal holdings on Monday, and together with executives of other drugmakers seeking a Covid-19 vaccine, including Moderna Inc. and Novavax Inc., who sold them after promising news. A lot of stocks about their coronavirus shots, and…
Source link
